4.6 Article

Glycine 184 in Nonstructural Protein NS1 Determines the Virulence of Influenza A Virus Strain PR8 without Affecting the Host Interferon Response

期刊

JOURNAL OF VIROLOGY
卷 84, 期 24, 页码 12761-12770

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00701-10

关键词

-

类别

资金

  1. Deutsche Forschungsgemeinschaft [Ko 1579/5-1]
  2. Wissenschaftliche Gesellschaft in Freiburg
  3. CRIP
  4. NIAID-funded Center for Research in Influenza Pathogenesis [HHSN266200700010C]
  5. NIAID [RO1AI46954, U19AI83025]

向作者/读者索取更多资源

The nonstructural protein NS1 of influenza A virus counteracts the interferon (IFN) system and thereby promotes viral replication. NS1 has acquired different mechanisms to limit induction of IFN. It prevents double-stranded RNA (dsRNA) and RIG-I-mediated activation of interferon regulatory factor 3 (IRF3), and it blocks posttranscriptional processing of cellular mRNAs by binding to the cleavage and polyadenylation specificity factor (CPSF). Using a mouse-adapted A/PR/8/34 virus and reverse genetics to introduce specific mutations in NS1 which eliminate one or both functions, we determined the relative contributions of these two activities of NS1 to viral virulence in mice. We found that a functional RNA-binding motif was required for IFN suppression and virulence. Restoration of CPSF binding in the NS1 protein of wild-type A/PR/8/34 virus, which cannot bind CPSF due to mutations in the central binding motif at positions 103 and 106, resulted in enhanced virulence. Surprisingly, if CPSF binding was abolished by substituting glycine for arginine at position 184 in the classical NS1-CPSF binding motif, the mutant virus replicated much more slowly in mice, although the mutated NS1 protein continued to repress the IFN response very efficiently. Our results show that a functional RNA-binding motif is decisive for NS1 of A/PR/8/34 virus to suppress IFN induction. They further demonstrate that in addition to its contribution to CPSF binding, glycine 184 strongly influences viral virulence by an unknown mechanism which does not involve the IFN system.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Chemistry, Multidisciplinary

Advanced Materials for SARS-CoV-2 Vaccines

Moustafa T. Mabrouk, Wei-Chiao Huang, Luis Martinez-Sobrido, Jonathan F. Lovell

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has led to millions of deaths globally and emphasized the importance of vaccines. Advanced technologies have enabled rapid development and deployment of COVID-19 vaccines, although access is limited in many developing countries. Different vaccine platforms and nanomaterials have been used to develop COVID-19 vaccines. Continued development of vaccine technologies is crucial for dealing with the ongoing and future pandemics.

ADVANCED MATERIALS (2022)

Article Virology

The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus

Wenjuan Dong, Heather Mead, Lei Tian, Jun-Gyu Park, Juan Garcia, Sierra Jaramillo, Tasha Barr, Daniel S. Kollath, Vanessa K. Coyne, Nathan E. Stone, Ashley Jones, Jianying Zhang, Aimin Li, Li-Shu Wang, Martha Milanes-Yearsley, Jordi B. Torrelles, Luis Martinez-Sobrido, Paul S. Keim, Bridget Marie Barker, Michael A. Caligiuri, Jianhua Yu

Summary: The K18-hACE2 mouse model provides a comprehensive analysis of SARS-CoV-2 infection and shows that different viral doses lead to varying degrees of organ damage. This model accurately reproduces both severe and non-severe COVID-19 in humans, making it valuable for drug development.

JOURNAL OF VIROLOGY (2022)

Article Virology

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice

Ting Y. Wong, Alexander M. Horspool, Brynnan P. Russ, Chengjin Ye, Katherine S. Lee, Michael T. Winters, Justin R. Bevere, Olivia A. Miller, Nathaniel A. Rader, Melissa Cooper, Theodore Kieffer, Julien Sourimant, Alexander L. Greninger, Richard K. Plemper, James Denvir, Holly A. Cyphert, Mariette Barbier, Jordi B. Torrelles, Ivan Martinez, Luis Martinez-Sobrido, F. Heath Damron

Summary: SARS-CoV-2 variants of concern (VoC) have enhanced immune evasion, as demonstrated in this study using passive immunization with human convalescent plasma (HCP). The efficacy of HCP generated to ancestral SARS-CoV-2 was tested against the Alpha, Beta, and Delta VoC in a mouse model. The results show that HCP was unable to control the lethality of these VoC strains, highlighting the need for in vivo models to evaluate emerging strains' immune evasion.

JOURNAL OF VIROLOGY (2022)

Review Multidisciplinary Sciences

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

Julien Sourimant, Carolin M. Lieber, Megha Aggarwal, Robert M. Cox, Josef D. Wolf, Jeong-Joong Yoon, Mart Toots, Chengin Ye, Zachary Sticher, Alexander A. Kolykhalov, Luis Martinez-Sobrido, Gregory R. Bluemling, Michael G. Natchus, George R. Painter, Richard K. Plemper

Summary: This study describes a drug called 4'-fluorouridine (4'-FlU), which has broad-spectrum antiviral effects and potential for the treatment of respiratory syncytial virus (RSV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and related RNA virus infections. In vitro and in vivo experiments showed that 4'-FlU inhibited RSV, SARS-CoV-2, and related RNA viruses with high efficacy, making it a promising candidate for broad-spectrum therapeutics against respiratory viruses.

SCIENCE (2022)

Article Physiology

Ataxia telangiectasia mutated is required for efficient proximal airway epithelial cell regeneration following influenza A virus infection

Rachel Warren, Andrew M. Dylag, Molly Behan, William Domm, Min Yee, Margot Mayer-Proschel, Luis Martinez-Sobrido, Michael A. O'Reilly

Summary: Children and young adults with mutant forms of the ATM gene, which is involved in DNA damage signaling and mitochondrial homeostasis, suffer from respiratory infections, immune deficiencies, and obstructive airways disease associated with disorganized airway epithelium. A study on mice showed that ATM is required for the regeneration of injured airway epithelium after influenza virus infection. Mice lacking ATM exhibited increased airway resistance and reduced lung compliance during infection, and their lungs developed an abnormal proximal airway epithelium containing cells lacking expression of the immunomodulatory protein Scgb1a1. Restoration of Scgb1a1 expression in the airways required ATM and failure to efficiently restore it may contribute to the respiratory diseases seen in individuals with ataxia telangiectasia.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2022)

Review Medical Laboratory Technology

Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review

Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, Adriel Pastrana, Jesus Alfonso Catahay, Gian Luca Salvagno, Eric Peng Huat Yap, Luis Martinez-Sobrido, Jordi B. Torrelles, Giuseppe Lippi, Brandon Michael Henry

Summary: This paper investigates the effects of age, sex, serostatus, and comorbidities on humoral response after mRNA-based Pfizer-BioNTech vaccination. The findings suggest that older individuals, males, seronegative individuals, and those with more comorbidities have a weaker humoral immune response.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2022)

Article Immunology

Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs

Sadaf Aslam, Madhusudan Rajendran, Divya Kriti, Andrew Kurland, Jeffrey Johnson, Harm van Bakel, Florian Krammer, Adolfo Garcia-Sastre, Juan Ayllon

Summary: To improve the production yield of seasonal influenza vaccines, we have identified optimal vaccine seed virus backbones for influenza B virus through research and evaluation in embryonated eggs. This study includes 71 strains of influenza B virus from 1940 to the present, representing the known temporal and genetic variability. By assessing the growth profiles and effectiveness of these strains, we selected three strains with the best performance as vaccine seed virus backbones to increase the production yield of influenza B virus seasonal vaccines.

NPJ VACCINES (2023)

Article Immunology

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models

Maria M. Lorenzo, Alejandro Marin-Lopez, Kevin Chiem, Luis Jimenez-Cabello, Irfan Ullah, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Gema Lorenzo, Sandra Moreno, Chengjin Ye, Jun-Gyu Park, Alejandro Matia, Alejandro Brun, Juana M. Sanchez-Puig, Aitor Nogales, Walther Mothes, Pradeep D. Uchil, Priti Kumar, Javier Ortego, Erol Fikrig, Luis Martinez-Sobrido, Rafael Blasco

Summary: The COVID-19 pandemic highlights the need for fast responses and reliable technologies for vaccine development. This study reports on the construction and preclinical testing of a recombinant MVA vaccine, with the MVA-Spf vaccine candidate showing higher levels of antibodies, a stronger T cell response, and a higher degree of protection.

VACCINES (2023)

Article Microbiology

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies

Michael Piepenbrink, Fatai Oladunni, Aitor Nogales, Ahmed M. Khalil, Theresa Fitzgerald, Madhubanti Basu, Christopher Fucile, David J. Topham, Alexander F. Rosenberg, Luis Martinez-Sobrido, James J. Kobie

Summary: Influenza A virus (IAV) infections pose a significant threat to public health due to the variable nature of the virus. This study shows that immunization with a seasonal inactivated influenza vaccine (IIV) can increase the levels of antibodies against H3N2 IAV, a strain known for its genetic drift. These antibodies have broad and potent antiviral activity and can protect against various H3N2 IAV strains. They also persist in the bone marrow, indicating their potential for long-term immunity. These findings contribute to the development of a universal influenza vaccine.

MICROBIOLOGY SPECTRUM (2023)

Article Microbiology

Identification of In Vitro Inhibitors of Monkeypox Replication

Kevin Chiem, Aitor Nogales, Maria Lorenzo, Desarey Morales Vasquez, Yan Xiang, Yogesh K. Gupta, Rafael Blasco, Juan Carlos de la Torre, Luis Martinez-Sobrido

Summary: Despite the eradication of smallpox, some orthopoxviruses, such as monkeypox virus (MPXV), remain important human pathogens. Vaccines for smallpox are effective against MPXV, but limited in access. Current antiviral treatments for MPXV are limited to two FDA-approved drugs. Therefore, there is an urgent need to discover novel antivirals for the treatment of MPXV and other potentially zoonotic orthopoxvirus infections. Here, we found 13 compounds that inhibit both VACV and MPXV, derived from two different libraries of compounds known to inhibit various RNA viruses.

MICROBIOLOGY SPECTRUM (2023)

Article Immunology

Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections

Luis Martinez-Sobrido, James J. Kobie

ANTIBODIES (2023)

Article Virology

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody

Ahmed M. Khalil, Michael S. Piepenbrink, Ian Markham, Madhubanti Basu, Luis Martinez-Sobrido, James J. Kobie

Summary: IBV contributes significantly to morbidity and mortality, particularly in children, necessitating improvements in vaccines and treatments. A specific hMAb, 1092D4, has been found to have minimal dependence on Fc-effector functions for in vivo antiviral activity.

VIRUSES-BASEL (2023)

Article Immunology

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

Sonia Jangra, Jeffrey J. Landers, Gabriel Laghlali, Raveen Rathnasinghe, Prajakta Warang, Seok-Chan Park, Jessica. J. O'Konek, Gagandeep Singh, Katarzyna W. Janczak, Adolfo Garcia-Sastre, Nandini Arya, Dilara Karadag, Jr James R. Baker, Michael Schotsaert, Pamela T. Wong

Summary: Multiple FDA-approved vaccines provide good protection against severe disease caused by SARS-CoV-2. However, immunity can decline quickly, especially in the elderly, and new viral variants are emerging that can evade the immune response induced by infection or vaccination. Intranasal vaccination is more effective in inducing mucosal immune responses than injectable vaccines, which can improve protection and reduce viral transmission.

NPJ VACCINES (2023)

Review Immunology

Engineering Non-Human RNA Viruses for Cancer Therapy

Vicent Tur-Planells, Adolfo Garcia-Sastre, Sara Cuadrado-Castano, Estanislao Nistal-Villan

Summary: This review provides an overview of non-human-adapted RNA viruses used in cancer therapy and the diverse strategies employed to optimize their therapeutic capabilities. Through this article, we gain insights into the promising advancements in virotherapy and its potential to revolutionize cancer treatment.

VACCINES (2023)

Review Immunology

Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution

Ahlam Alasiri, Raya Soltane, Akram Hegazy, Ahmed Magdy Khalil, Sara H. Mahmoud, Ahmed A. Khalil, Luis Martinez-Sobrido, Ahmed Mostafa

Summary: Despite being widespread in wild birds and domestic poultry, human infections with highly pathogenic avian influenza H5Nx viruses have been limited since 1996. Few countries use vaccination as a control strategy, while most rely on culling infected flocks. China and Egypt are the major sites where vaccination has been employed, particularly for clade 2.3.4.4b H5N1 viruses. However, improper implementation of control strategies in Egypt has resulted in continuous outbreaks and virus evolution. Comprehensive surveillance in endemic areas is crucial to understand the public health risk of newly emerging immune-evasive or drug-resistant H5Nx variants.

VACCINES (2023)

暂无数据